首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
A confirmed first-line option for CLL
被引:0
|
作者
:
Rebecca Kirk
论文数:
0
引用数:
0
h-index:
0
Rebecca Kirk
机构
:
来源
:
Nature Reviews Clinical Oncology
|
2011年
/ 8卷
/ 5期
关键词
:
D O I
:
10.1038/nrclinonc.2011.38
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:253 / 253
相关论文
共 50 条
[41]
Fludarabine, cyclophosphamide and rituximab (FCR) first-line therapy in CLL patients: an analysis of the registry of the German CLL Study Group
论文数:
引用数:
h-index:
机构:
Fink, A. M.
Federhen, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Federhen, A.
论文数:
引用数:
h-index:
机构:
Kutsch, N.
Stumpf, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Stumpf, J.
Giza, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Giza, A.
Robrecht, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Robrecht, S.
Stoltefuss, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Evangel Krankenhaus Hamm, Klin Innere Med 2, Hamm, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Stoltefuss, A.
Vehling-Kaiser, U.
论文数:
0
引用数:
0
h-index:
0
机构:
UBAG MVZ Dr Vehling Kaiser GmbH, Landshut, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Vehling-Kaiser, U.
Koenigsmann, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Onkol Ambulanzzentrum Hannover, Hannover, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Koenigsmann, M.
Tausch, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Ulm, Div CLL, Dept Internal Med 3, Ulm, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Tausch, E.
Schneider, C.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Ulm, Div CLL, Dept Internal Med 3, Ulm, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Schneider, C.
Stilgenbauer, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Ulm, Div CLL, Dept Internal Med 3, Ulm, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Stilgenbauer, S.
Illmer, T.
论文数:
0
引用数:
0
h-index:
0
机构:
BAG Freiberg Richter, GEMEINSCHAFTSPRAXIS Hamatol Onkol, Dresden, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Illmer, T.
Schlag, R.
论文数:
0
引用数:
0
h-index:
0
机构:
Hamatol Onkol Schwerpunktpraxis Wurzburg, Wurzburg, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Schlag, R.
Doerfel, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Onkozentrum Dresden Freiberg, Dresden, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Doerfel, S.
Gaska, T.
论文数:
0
引用数:
0
h-index:
0
机构:
Bruderkrankenhaus St Josef Paderborn, Klin Hamatol & Onkol, Paderborn, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Gaska, T.
Kiehl, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Klinikum Frankfurt Oder, Med Klin 1, Frankfurt, Oder, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Kiehl, M.
论文数:
引用数:
h-index:
机构:
Fischer, K.
Eichhorst, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Eichhorst, B.
论文数:
引用数:
h-index:
机构:
Hallek, M.
ONCOLOGY RESEARCH AND TREATMENT,
2022,
45
(SUPPL 2)
: 119
-
120
[42]
First line therapy of CLL
Hallek, Michael
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Cologn, Dept Internal Med 1, Cologne, Germany
Ctr Integrated Oncol Aachen Bonn Koln Dusseldorfe, Bonn, Germany
Univ Cologne, Ctr Excellence Cellular Stress Responses Aging Ass, Cologne, Germany
Univ Cologne, Med Fac, Dep Internal Med I, Kerpener Str 62, D-50937 Cologne, Germany
Univ Cologn, Dept Internal Med 1, Cologne, Germany
Hallek, Michael
HEMATOLOGICAL ONCOLOGY,
2023,
41
: 129
-
135
[43]
SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
Ghielmini, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Oncol Inst So Switzerland, Bellinzona, Switzerland
Oncol Inst So Switzerland, Bellinzona, Switzerland
Ghielmini, M.
ANNALS OF ONCOLOGY,
2011,
22
: 81
-
81
[44]
Necitumumab: a new option for first-line treatment of squamous cell lung cancer
Jimenez Aguilar, Elizabeth
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Inst Invest I 12, Madrid, Spain
CNIO, Lung Canc Grp, Clin Res Program, Madrid, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Jimenez Aguilar, Elizabeth
Zugazagoitia Fraile, Jon
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Inst Invest I 12, Madrid, Spain
CNIO, Lung Canc Grp, Clin Res Program, Madrid, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Zugazagoitia Fraile, Jon
Paz-Ares Rodriguez, Luis
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Inst Invest I 12, Madrid, Spain
CNIO, Lung Canc Grp, Clin Res Program, Madrid, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Univ Complutense Madrid, Med Oncol Dept, Madrid, Spain
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
Paz-Ares Rodriguez, Luis
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY,
2018,
14
(08)
: 765
-
772
[45]
Surgery: Laparoscopic sleeve gastrectomy as the first-line surgical option for morbid obesity
Heath V.
论文数:
0
引用数:
0
h-index:
0
Heath V.
Nature Reviews Endocrinology,
2010,
6
(10)
: 534
-
534
[46]
Advanced Hepatocellular Carcinoma New effective Option in First-line Therapy: Lenvatinib
不详
论文数:
0
引用数:
0
h-index:
0
不详
ONCOLOGY RESEARCH AND TREATMENT,
2019,
42
(04)
: 228
-
229
[47]
Platelet-rich fibrin is the first-line treatment option for periodontal regeneration
Su, Ni-Yu
论文数:
0
引用数:
0
h-index:
0
机构:
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Chung Shan Med Univ, Sch Dent, 110,Sect 1,Chien Kuo North Rd, Taichung, Taiwan
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Su, Ni-Yu
Yang, Li-Chiu
论文数:
0
引用数:
0
h-index:
0
机构:
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Chung Shan Med Univ, Sch Dent, 110,Sect 1,Chien Kuo North Rd, Taichung, Taiwan
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Yang, Li-Chiu
Chang, Yu-Chao
论文数:
0
引用数:
0
h-index:
0
机构:
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Chung Shan Med Univ, Sch Dent, 110,Sect 1,Chien Kuo North Rd, Taichung, Taiwan
Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
Chang, Yu-Chao
JOURNAL OF DENTAL SCIENCES,
2017,
12
(03)
: 203
-
204
[48]
Fexofenadine a first-line option for seasonal allergic rhinitis and chronic idiopathic urticaria
不详
论文数:
0
引用数:
0
h-index:
0
不详
Drugs & Therapy Perspectives,
2000,
16
(8)
: 1
-
5
[49]
Ketamine is a good first-line option for severely agitated patients in the prehospital environment
Miner, James R.
论文数:
0
引用数:
0
h-index:
0
机构:
Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA
Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA
Miner, James R.
AMERICAN JOURNAL OF EMERGENCY MEDICINE,
2018,
36
(03):
: 501
-
502
[50]
Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas
Laimer, Gregor
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Laimer, Gregor
Schullian, Peter
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Schullian, Peter
Scharll, Yannick
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Scharll, Yannick
Putzer, Daniel
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Putzer, Daniel
Eberle, Gernot
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Eberle, Gernot
Oberhuber, Georg
论文数:
0
引用数:
0
h-index:
0
机构:
Tirol Kliniken Innsbruck, Inst Pathol, INNPATH, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Oberhuber, Georg
Bale, Reto
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Med Univ Innsbruck, Dept Radiol, Intervent Oncol Microinvas Therapy SIP, Innsbruck, Austria
Bale, Reto
INTERNATIONAL JOURNAL OF HYPERTHERMIA,
2022,
39
(01)
: 780
-
787
←
1
2
3
4
5
→